Global PCR for POC Diagnostics Market 2022-2028

Global PCR for POC Diagnostics Market 2022-2028

Sometimes called molecular photocopying, the polymerase chain reaction (PCR) is a fast and inexpensive technique used to amplify - copy - small segments of DNA. PCR is valuable in a number of laboratory and clinical techniques, including DNA fingerprinting, detection of bacteria or viruses, and diagnosis of genetic disorders. Gen Consulting Company predicts that the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market is estimated to touch a valuation of USD 5,264 million, registering a CAGR of 8.5% during the forecast period (2022-2028).

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the polymerase chain reaction (PCR) for point-of-care (POC) diagnostics industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, and region. The global market for polymerase chain reaction (PCR) for point-of-care (POC) diagnostics can be segmented by product: equipment, kits. Kits held the largest share in the global pcr for poc diagnostics market in 2021 and is projected to portray the fastest growth rate in the coming years. Polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market is further segmented by region: Asia Pacific, Europe, North America, Rest of the World (RoW). In 2021, North America made up the largest share of revenue generated by the polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market.

By product:

• equipment
• kits

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The equipment market is further segmented into multi-kit, single kit. Gen Consulting Company research indicates that the single kit segment occupied the largest share of this market in 2021 and is expected to draw the highest demand in coming years. Furthermore, the kit market has been categorized into infectious disease, multi-analyte panels, sexually transmitted diseases (STDs), single analyte, others. Globally, the single analyte segment made up the largest share of the polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market.

The report also provides analysis of the key companies of the industry and their detailed company profiles including Abbott Laboratories Inc., Bio-Rad Laboratories, Inc., Cepheid, Qiagen N.V., Roche Holding AG, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market.
• To classify and forecast the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market based on product, region.
• To identify drivers and challenges for the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market.
• To identify and analyze the profile of leading players operating in the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market.

Why Choose This Report

• Gain a reliable outlook of the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.